(New York Post) Immunity from Moderna Inc.’s COVID-19 vaccine should last at least a year, the company said Monday at the J.P. Morgan Healthcare conference.
The drugmaker said it was confident that the messenger RNA (mRNA) technology it used was well suited to deploy a vaccine based on the new variant of the coronavirus that has emerged in a handful of countries.